Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Five Resolutions for Nominations Committees to Improve Board Performance

The New Year brings a period of reflection, what will you change in the year ahead and how will you do it? There are some clear ways in which the effectiveness of the board can be improved by the way in which the nominations and governance committee discharge their responsibilities. Here we listed 5 resolutions for an effective nominations committee.  Click the following links to read detailed articles on each recommendation.

Read the full article…

Posted in Corporate Governance | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Hans Schikan new Chair at InteRNA and Asceneuron

Hans Schikan is former Chief Executive Officer of Prosensa, a biopharmaceutical company focusing on novel RNA modulating treatments for rare diseases like Duchenne muscular dystrophy. Prosensa was listed on NASDAQ (RNA) since June 2013. The company was acquired by BioMarin early 2015 for up to USD 840 million. Before joining Prosensa, Hans worked at Genzyme, including as Vice President for Global Marketing and Strategic Development of Genzyme’s product portfolio for rare genetic diseases. Prior to Genzyme, he worked at Organon, both at corporate level and in country operations which included assignments in Asia and Europe.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , | Leave a comment

Kuros Biosurgery Closes Round at CHF 20m

Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products and focused in therapeutic areas covering sealants and orthobiologics, today announces that it has raised an additional CHF 5 million in a fully subscribed second closing of its financing round. The CHF 5 million was raised from a group of non-disclosed new and existing investors and brings the total raised in the round to CHF 20 million.

Read the full article…

Posted in M&A Finance and Funding | Tagged , , , , , , | Leave a comment

Pharming snares ex-Karolinska Development CFO

Pharming Group NV (EURONEXT: PHARM) proposed the election of Mr Robin Wright as the Company’s new Chief Financial Officer (CFO) and member of the Management Board at an Extraordinary General Meeting (“EGM”) of shareholders, to be held on Wednesday 28 October 2015 at 14:00 hrs CET.

Read the full article…

Posted in Board Director Appointments, Executive Appointments | Tagged , , , , , , | Leave a comment

Audion Therapeutics has Investors Listening

Audion Therapeutics is a Netherlands based biotech developing therapeutics in the area of hearing loss, an area that has garnered serious interest from investors against the backdrop of an ageing population. This investor sentiment has meant that Audion Therapeutics was able to raise €2.5 million Series B investment from INKEF Capital, a Netherlands based venture capital firm. In addition, Audion announced that, together with a strong international consortium of development partners, it was awarded a 5.8 million Euro grant through the Horizon 2020 program, an important funding source for many European biotechs. The combined funds of €8.3 million enable Audion to progress its lead program targeting sensorineural hearing loss to clinical Proof of Concept.

Read the full article…

Posted in M&A Finance and Funding | Tagged , , , , , , , | Leave a comment

Hans Schikan appointed Chairman of Complix

Complix, a biopharmaceutical company focused on developing a pipeline of transformative protein therapeutics, called Alphabodies™, mainly focused on oncology and autoimmune diseases, today announced the appointment of Hans Schikan as Chairman of its Board of Directors.  

Read the full article…

Posted in Executive Appointments | Tagged , , , , , , , , , , , , , , , | Leave a comment

Biotechnology must embrace a more diverse future of leadership

Authored by Karl Simpson

Read the full article…

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Prosensa begins FDA submission process for DMD drug

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , | Leave a comment

AM-Pharma raises 12.2m Euros

Authored by James Sheppard

Read the full article…

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , | Leave a comment

Merck announces collaboration with Advaxis

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap